ProQR Therapeutics (PRQR) Goodwill & Intangibles (2013 - 2018)
ProQR Therapeutics recorded quarterly Goodwill & Intangibles of -$44514.5 in Q4 2018, down 98231.53% quarter-over-quarter from $45.36 in Q3 2018, and down 196.94% year-over-year from $45919.9 in Q4 2017.
ProQR Therapeutics' Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at -$44514.5 for Q4 2018.
- In Q4 2018, Goodwill & Intangibles fell 196.94% year-over-year to -$44514.5; the TTM figure through Dec 2018 stood at -$44514.5 (down 196.94% YoY), while the FY2018 annual figure was -$44514.5, down 196.94% from the prior year.
- Goodwill & Intangibles came in at -$44514.5 for Q4 2018 at ProQR Therapeutics, down from $45.36 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $203722.9 in Q4 2014 to a low of -$44514.5 in Q4 2018.
- A 5-year average of $66100.7 and a median of $46544.3 in 2018 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles jumped 283.79% in 2014 and tumbled 196.94% in 2018, its largest moves.
- ProQR Therapeutics' Goodwill & Intangibles stood at $203722.9 in 2014, then retreated by 24.14% to $154552.5 in 2015, then sank by 37.12% to $97175.2 in 2016, then tumbled by 52.75% to $45919.9 in 2017, then sank by 196.94% to -$44514.5 in 2018.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered -$44514.5, $45.36, and $46544.3 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -44,514.46 |
| Sep 30, 2018 | 45.36 |
| Jun 30, 2018 | 46,544.33 |
| Mar 31, 2018 | 47.91 |
| Dec 31, 2017 | 45,919.87 |
| Dec 31, 2016 | 97,175.18 |
| Sep 30, 2016 | 114.97 |
| Dec 31, 2015 | 154,552.54 |
| Mar 31, 2015 | 171,734.54 |
| Dec 31, 2014 | 203,722.86 |
| Sep 30, 2014 | 51,764.37 |
| Dec 31, 2013 | 53,082.49 |